ReviewDiagnostics (Basel, Switzerland)2025
Mechanisms and Impact of Cognitive Reserve in Normal Aging and Alzheimer's Disease.
Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Long-Term Cognitive and Functional Outcomes of Anesthesia and Surgery in Patients with Dementia.Healthcare (Basel, Switzerland) · 2026Review
- Cerebrospinal Fluid Transforming Growth Factor β Isoforms and Disease Progression in Alzheimer's Disease: Longitudinal Evidence from the ADNI Cohort.Neurology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Age-related cognitive decline and individual differences in dementia susceptibility are increasingly explained through the concept of cognitive reserve (CR). CR reflected the brain's adaptive capacity to sustain cognitive performance despite Alzheimer's disease (AD)-related pathology, extending beyond traditional biomarkers that captured the molecular or structural changes, but often failed to account for clinical heterogeneity. This review provided a comprehensive synthesis of how CR was operationalized through three major methodological approaches: sociobehavioral proxies, residual variance frameworks, and neurobiological indicators within the context of longitudinal study designs. The review included evidences from a structured PubMed and Scopus search restricted to English-language studies examining the incidence of mild cognitive impairment (MCI) or AD. Findings consistently demonstrated that higher CR, most commonly estimated through sociobehavioral proxies, such as educational level, occupational complexity, bilingualism, and engagement in cognitively stimulating activities, was associated with a delayed onset of impairment, lower dementia risk, and better clinical outcomes, despite a comparable neuropathological burden. Residual variance approaches provided complementary insights by quantifying cognitive performance that exceeded the predicted levels from underlying pathology, thereby capturing unexplained variance by structural or molecular disease markers. These residual-based methods extend CR concept beyond life-course experiences, offering statistical evidence of resilience within longitudinal trajectories of aging and disease. Additional evidence from electrophysiological and genetic investigations further suggested that CR enhanced the neural efficiency, flexibility, and the recruitment of compensatory networks. Finally, neuroimaging studies provided the mechanistic evidence that CR was supported by alterations in brain structure, functional connectivity, and activation patterns, though findings on long-term trajectories remained inconsistent. Overall, CR emerged as a multidimensional and modifiable construct that enhanced resilience to aging and dementia. Future research should prioritize the integrative longitudinal designs, combining sociobehavioral, residual variance, genetic, electrophysiological, and neuroimaging approaches to clarify mechanisms, establishing robust measurement frameworks and advance clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.